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 WHAT ROLE SHOULD PUBLIC OPINION PLAY IN ETHICO-LEGAL DECISION 
MAKING?: THE EXAMPLE OF SELECTING SEX FOR NON-MEDICAL 
REASONS USING PREIMPLANTATION GENETIC DIAGNOSIS 
 
Summary 
In this article we consider the prohibition on the use of preimplantation genetic diagnosis to 
select an embryo on the basis of its sex for non-medical reasons.  We use this as a case study 
to explore the role that public consultations have and should play in ethico-legal decision 
making.  Until the Human Fertilisation and Embryology Act 1990 was amended by the 
Human Fertilisation and Embryology Act 2008, non-medical sex selection of an embryo was 
not statutorily regulated but it was the policy of the Human Fertilisation and Embryology 
Authority that such selection should not occur.  However, since 2009 it has been a criminal 
offence to select an embryo on the basis of its sex for non-medical reasons.  We consider the 
reasons given for this change and explore the role that ‘public opinion’ had in the decision-
making process.  On the face of it, asking the public what they think seems reasonable, fair 
and democratic, and those who are not in favour of public consultations being accorded great 
weight in matters of policy may appear out of touch and as wanting to impose their moral 
views on the public at large.  But there are problems with doing so, especially when seeking 
to regulate ethically controversial issues.  We discuss whether regulation should be 
influenced by public opinion obtained via ‘public consultations’, and utilise sex selection for 
non-medical reasons as an example of how (apparently) public opinion was used to support 
the criminalisation of this practice. 
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Folklore around how to conceive a child of a particular sex is widespread and ultrasounds can 
be used to detect the sex of a foetus at about 20 weeks gestation.  However, it was not until 
the end of the 1980s that technology advanced so that an embryo could be tested and its sex 
identified at a very early stage in its development.  In 1989 it was reported that researchers in 
England had successfully used preimplantation genetic diagnosis (PGD) to identify the sex of 
an embryo,1 and three years later it was reported that a ‘normal girl’ had been born following 
in vitro fertilisation (IVF) and PGD testing for cystic fibrosis.2  Embryos created via IVF can 
undergo PGD when the embryo is about two to three days in development and consists of 
about eight cells.   One or two cells are removed from the embryo and these can be tested to 
detect a genetic condition.3  Neither IVF nor PGD were statutorily regulated in 1989 and 
while IVF was subsequently regulated by the original Human Fertilisation and Embryology 
Act 1990, using PGD in the treatment context was not.  Thus, between 1991 (when the 
original 1990 Act came into force) and 2009 (when the amendments introduced to that Act by 
the Human Fertilisation and Embryology Act 2008 came into force) guidance on using PGD 
was only provided by the Human Fertilisation and Embryology Authority (HFEA) in its non-
legally binding Code of Practice.  This has now changed.  Under the amended 1990 Act PGD 
may be used in certain circumstances, including to identify the sex of an embryo, if the 
HFEA has granted a licence to the clinic for this, and then only for medical reasons.4  
                                                          
1 AH Handyside and others, ‘Biopsy of human preimplantation embryos and sexing by DNA amplification’ 
(1989) 333 Lancet 347. 
2 AH Handyside and others, ‘Birth of a normal girl after in vitro fertilization and preimplantation diagnostic 
testing for cystic fibrosis’ (1992) 327 New England Journal of Medicine 905, 905. 
3 See HFEA, ‘Pre-implantation Genetic Diagnosis (PGD)’ (2014) <http://www.hfea.gov.uk/preimplantation-
genetic-diagnosis.html> accessed 17/11/15. 
4 1990 Act, ss 3(1)-(1A), 11, and Sched 2, paras 1ZA-B.  All references are to the 1990 Act as amended by the 
Human Fertilisation and Embryology Act 2008 unless stated otherwise. 
 Notably, it is now a criminal offence to perform PGD without a licence, outside the terms of 
a licence, or use to it to select an embryo on the basis of its sex for non-medical reasons.5  
Therefore, while some of the amendments introduced by the 2008 Act have been viewed (by 
some) as (unduly) permissive and liberal, such as those relating to section 13(5) and the 
concept of the welfare of the child, reproductive choice has not been expanded for all.  
Previously the HFEA could have altered its position and permitted non-medical sex selection 
under its Code of Practice.  Now any such changes will require legislative action, with all the 
difficulties that follow from this.  We acknowledge that it could be seen as ‘dangerous’ for 
controversial questions to be dealt with away from Parliament, but our focus here is not on 
the role of Parliament or other bodies in this regard per se.  Rather, we are concerned with the 
use of ‘public opinion’ to support the prohibition of specific practices, with sex selection for 
non-medical reasons our example. 
 
We are interested in how and why it was decided that it was necessary and appropriate that it 
should be illegal to use PGD to select an embryo on the basis of its sex on non-medical 
grounds.6  The HFEA has authorised PGD in the UK for over 100 inherited conditions,7 
thereby allowing parents to test for inherited disorders and implant embryos that are not 
affected by those genetic traits.  PGD can also be used to identify the sex of an embryo and 
this might occur for medical or non-medical reasons.  PGD can be used to identify usually 
female embryos in order to implant them to avoid certain sex linked genetic disorders, such 
as Duchenne muscular dystrophy and haemophilia A and B.  Females may carry sex linked 
                                                          
5 1990 Act, s 41(2). 
6 We are not interested here in the ethics of PGD per se.  For discussion on this see, for eg., S Wilkinson and E 
Garrard, Eugenics and the Ethics of Selective Reproduction (Keele University: Keele, 2013); D King, 
‘Preimplantation genetic diagnosis and the “new eugenics’ (1999) 25 Journal of Medical Ethics 176; C 
Gavaghan, ‘Right problem wrong solution: A pro-choice response to “expressivist” concerns about 
preimplantation genetic diagnosis’ (2007) 16 Cambridge Quarterly of Healthcare Ethics 20. 
7 For a list of the conditions that can be tested for see HFEA, ‘PGD conditions licensed by the HFEA’ (2015): 
<http://www.hfea.gov.uk/cps/hfea/gen/pgd-screening.htm> accessed 17/11/15. 
 disorders but they rarely inherit two copies of the gene responsible and so are unlikely to 
suffer from these diseases, but males only need to inherit one affected gene to inherit the 
disease and they have a 50% chance of doing so if their genetic mother is a carrier of the 
gene.  In other cases, such as Fragile X syndrome, conditions are more severely expressed in 
one sex than the other.  Thus, if only female embryos are implanted the risk of producing a 
child with these disorders can be avoided.  In contrast, an embryo’s sex might be identified 
for non-medical reasons because the would-be parents have a preference for a child of that 
sex.  Using PGD to select female embryos to implant to avoid a child being born with a sex 
related genetic disorder is legally acceptable,8 and usually deemed morally acceptable if not 
desirable,9 but selecting an embryo on the basis of its sex for non-medical reasons is more 
controversial,10 and is now punishable by two years imprisonment, a fine or both.11 
 
In Part II we consider the regulation of sex selection for non-medical reasons and then 
examine the basis for prohibiting this use of PGD in Part III,  before exploring problems with 
using public opinion as a basis for regulation in Part IV.  We argue that while there appears to 
be agreement that the State should, and needs to, take a stance on ethically controversial 
issues in order to draw a clear line between what is legally permitted and prohibited in areas 
where personal opinions are strongly held, policy makers and legislators are increasingly 
faced with difficult decisions about how to regulate such issues in areas where debate is 
polarised and there is little chance of consensus.  We suggest that a position must be taken 
                                                          
8 Permitted under 1990 Act, Sched 2, para 1ZA. 
9 Ethics Committee of the American Society for Reproductive Medicine, ‘Use of preimplantation genetic 
diagnosis for serious adult onset conditions: A committee opinion’ (2013) 100 Fertility and Sterility 54; JA 
Robertson, ‘Extending preimplantation genetic diagnosis: Medical and non-medical uses’ (2003) 29 Journal of 
Medical Ethics 213. 
10 For contrary views see, for eg., JA Robertson and T Hickman, ‘Should PGD be used for elective gender 
selection?: A discussion of the ethics of the use of gender selection for nonmedical reasons’ (2013) 
Contemporary OB/GYN <http://contemporaryobgyn.modernmedicine.com/contemporary-obgyn/news/should-
pgd-be-used-elective-gender-selection> accessed 17/11/15. 
11 1990 Act, ss 3(1)-(1A), 11, 41(2), and Sched 2, paras 1ZA-B. 
 that can be defended as the most reasonable solution to a particular ethical problem and, in 
Part V, we question whether reliance on public opinion can and should aid in this regard. 
 
II. THE REGULATION OF SEX SELECTION FOR NON-MEDICAL REASONS 
 
When PGD was first successfully used in the UK it was not statutorily regulated, despite the 
fact that the possibility of sex selection and testing an embryo had been recognised by the 
Warnock Committee in their 1984 Report.12  They commented that ‘[w]e see no reason why, 
if a method of selecting the sex of a child before fertilisation is developed, this should not be 
offered to couples who have good medical reasons for choosing the sex of their child’.13  
While the original 1990 Act addressed using PGD in the research context and a research 
licence could be granted in order to develop methods ‘for detecting the presence of gene or 
chromosome abnormalities in embryos before implantation’,14 it did not expressly state that a 
treatment licence could authorise the clinical use of PGD.15  In 1993 the HFEA declared that 
PGD could be used to identify the sex of an embryo for medical reasons,16 and the third 
edition of its Code of Practice, in 1995, was the first to include anything on selecting an 
embryo on the basis of its sex.  It stated that ‘[c]entres should not select the sex of embryos 
for social reasons’,17 and this provision has been included in every subsequent Code.18  A 
                                                          
12 Department of Health and Social Security, Report of the Committee of Inquiry into Human Fertilisation and 
Embryology (1984) Cmnd. 9314, Ch 9 (Warnock Report). 
13 Warnock Report, n 12 above, para 9.11, emphasis supplied. 
14 Original 1990 Act, Sched 2, para 3(2)(e). 
15 Original 1990 Act, s 11, Sched 2, para 1.  For a history of the regulation of PGD in the UK see E Jackson, 
‘Statutory Regulation of PGD in the UK: Unintended Consequences and Future Challenges’ in SAM McLean 
and S Elliston (eds) Regulating Pre-implantation Genetic Diagnosis: A Comparative and Theoretical Analysis 
(Routledge: Oxford, 2013). 
16 Human Fertilisation and Embryology Authority (HFEA), Sex Selection Public Consultation Document 
(HFEA: London, 1993) paras 17 and 42. 
17 HFEA, Code of Practice (HFEA: London, 3rd edn, 1995) para 7.20. 
18 Subsequently, HFEA, Code of Practice (HFEA: London, 4th edn, 1998) para 7.20; HFEA, Code of Practice 
(HFEA: London, 5th edn, 2001) para 9.9; HFEA, Code of Practice (HFEA: London, 6th edn, 2003) paras 8.9, 
14.10, Appendix H – p 159; HFEA, Code of Practice (HFEA: London, 7th edn R4, 2008) G.8.7.1, Appendix A - 
A.13.7, A.13.9, A.13.11; HFEA, Code of Practice (HFEA: London, 8th edn R8, 2015) paras 9B, T88, 10D.  The 
prohibition on using sperm sorting for sex selection purposes has similarly been prohibited: HFEA, Code, 4th 
 framework for and guidance on the use of PGD was included in the sixth edition of the Code, 
in 2003, which covered matters such as licensing, genetic counselling, patient information 
and clinical decision-making, including the s 13(5) obligation to consider the welfare of the 
child.19  But the Code is not legally binding and it is not a criminal offence to breach it, 
although a licence committee can take any breaches of it into account when deciding whether 
to vary or revoke a licence.20  With regard to ‘formal’ regulation, in 2005 the House of Lords 
confirmed that PGD fell within the HFEA’s licensing jurisdiction,21 and Regulations were 
introduced in 2007 to amend the original 1990 Act to make it clear that a licence from the 
HFEA could authorise ‘procuring, keeping, testing, processing or distributing embryos’.22  
Thus, from 1991 (when the 1990 Act came into force) until 2007 neither PGD nor sex 
selection were formally regulated.  While it was the HFEA’s policy not to license the use of 
PGD to select an embryo of a particular sex for non-medical reasons, it was not illegal to do 
so.23 
 
Concern about the regulation of human fertilisation and embryology generally was growing 
during the 2000s and there was a sense that the science was developing at a pace which was 
outstripping the regulatory framework.  During 2005 the House of Commons Science and 
Technology Committee published a report on human reproduction, which included sex 
                                                                                                                                                                                    
edn, para 7.21 (any reason); HFEA, Code, 5th edn, para 9.10 (any reason); HFEA, Code, 7th edn, G.8.7.2 (any 
reason).  However, the most recent Code permits sperm sorting for medical reasons provided the patient 
receives information about the ‘process, procedures, possible risks and the experience of the clinic in doing the 
procedure’ (HFEA, Code, 8th edn, para 10.20), but gradient methods should not be used for medical reasons 
because of the technique’s unreliability (para.10.19). 
19 HFEA, Code, 6th edn, n 18 above, Part 14. Subsequently, HFEA, Code, 7th edn, n 18 above, G.12, Appendix 
A A.13.7-A13.9; HFEA, Code, 8th edn, n 18 above, Sections 9-10. 
20 1990 Act, s 25. 
21 R (Josephine Quintavalle) v. HFEA [2005] UKHL 28, [35] per Lord Hoffman; [62] per Lord Brown. 
22 Under Human Fertilisation and Embryology (Quality and Safety Regulations) 2007/1522, para 29. 
23 Note that selecting an embryo on the basis of its sex for ‘social reasons’ is prohibited under Article 14 of the 
European Convention on Human Rights and Biomedicine 1997.  This Convention has not been signed or 
ratified by the UK. 
 selection,24 and in its response the Government adopted and endorsed the position in the 
HFEA’s Code of Practice that licensed clinics may not use information derived from tests on 
an embryo or material removed from it to select embryos of a particular sex for non-medical 
reasons.25  The Department of Health conducted a review of and public consultation on the 
1990 Act in 2005, including the use and regulation of sex selection.26  A White Paper was 
published in December 2006 in which it was said that ‘the Government believes that there is 
a general desire for the law to be clearer on [screening and selecting embryos], and hence for 
Parliament to define some limits or criteria that apply to testing of embryos’.27  In May 2007 
a draft bill was published which included a statutory prohibition on selecting an embryo on 
the basis of sex for non-medical reasons,28 and a Joint Parliamentary Committee was 
appointed to scrutinise it.  The Committee recommended that sex selection for non-medical 
reasons was not permitted, was concerned that the wording in the draft bill was more 
restrictive than current HFEA policy, and recommended that the bill was amended in line 
with that policy.29  The Government accepted that recommendation,30 the Human 
Fertilisation and Embryology Bill (the HFE Bill) was amended accordingly and was 
introduced into the House of Lords in November 2007, with the prohibition on selecting sex 
for non-medical reasons one of the main provisions.31 
 
                                                          
24 House of Commons Science and Technology Committee, Human Reproductive Technology and the Law, 
Fifth Report of Session 2004-05 (2005), Volume I, HC 7-1, paras 131-142. 
25 HM Government, Human Reproductive Technologies and the Law: Government Response to the Report from 
the House of Commons Science and Technology Committee (2005) Cm 6641, para 45, response to 
Recommendations 29 and 30.  The Code applicable at the time was HFEA, Code, 6th edn, n 18 above, para 
14.10. 
26 Department of Health (DH), Review of the Human Fertilisation and Embryology Act: A Public Consultation 
(DH: London, 2005). 
27 DH, Review of the Human Fertilisation and Embryology Act: Proposals for revised legislation (including 
establishment of the Regulatory Authority for Tissue and Embryos), Cm 6989 (2006) para. 2.42. 
28 Human Tissue and Embryos (Draft) Bill, Cm 7087, Sched 2 para 1ZB. 
29 Joint Committee on the Human Tissue and Embryos (Draft) Bill, First Report (2007) paras 204-205: 
<http://www.publications.parliament.uk/pa/jt200607/jtselect/jtembryos/169/16902.htm> accessed 18/11/15.  
Also, paras 200-203.  For the Code at that time see HFE.A, Code, 6th edn, n 18 above, Part 14 
30 Government Response to the Report from the Joint Committee on the Human Tissue and Embryos (Draft) Bill, 
Cm 7209 (TSO 2007) Recommendation 18 and paras 44-45. 
31 HL Deb 19 November 2007, cols 665-667. 
 The Human Fertilisation and Embryology Act 2008 received Royal Assent in November 
2008 and the amendments to the 1990 Act came into force on 1 October 2009.  PGD in both 
the research and treatment contexts can now only be performed under a licence from the 
HFEA, a licence can only authorise embryo testing for certain purposes, and PGD can only 
be licensed to identify an embryo’s sex for medical purposes.32  The HFEA can only issue a 
treatment licence which authorises testing an embryo33 (a) to establish whether an embryo 
has an abnormality which might affect its ability to result in a live birth, (b) where there is a 
‘particular risk’ that an embryo might have an abnormality to establish whether it has it, or 
(c) where there is a ‘particular risk’ that any resulting child will have or develop a gender-
related ‘serious physical or mental disability’, ‘serious medical illness’, or ‘serious medical 
condition’.34  A licence can only authorise testing embryos under (b) if the HFEA is satisfied 
that there is a ‘significant risk’ that the resulting child will have or develop a ‘serious physical 
or mental disability, illness or any other serious medical condition’,35 and with regards to (c), 
a physical or mental disability, illness or condition is gender-related if the HFEA is satisfied 
that ‘(a) it affects only one sex or (b) affects one sex significantly more than other’.36 
 
Since the sixth edition of the HFEA’s Code of Practice the meanings of ‘significant risk’ and 
‘serious’ have been deemed to be matters for those seeking treatment and their treatment 
team, with factors listed for consideration when determining the appropriateness of using 
PGD for medical reasons.37  The current Code states that in determining whether PGD is 
appropriate in a particular case the centre should consider: 
                                                          
32 See n 3 above. 
33 1990 Act, Sched 2, para 1(1)(b). 
34 1990 Act, Sched 2, para 1ZA(1). 
35 1990 Act, Sched 2, para 1ZA(2). 
36 1990 Act, Sched 2, para 1ZA(3). 
37 HFEA, Code, 6th edn, n 18 above, paras 14.22-14.23; HFEA, Code, 7th edn, n 18 above, paras G.12.3.2-
G.12.3.3; HFEA, Code, 8th edn, n 18 above, paras 10.5-10.7.  On determining the seriousness of a disease see, 
for example, R Scott, C Williams, K Ehrich, and B Farsides, ‘The appropriate extent of preimplantation genetic 
diagnosis: Health professionals’ and scientists’ view on the requirement for a significant risk of a serious genetic 
  
(a) the views of the people seeking treatment in relation to the condition to be 
avoided, including their previous reproductive experience 
(b) the likely degree of suffering associated with the condition 
(c) the availability of effective therapy, now and in the future 
(d) the speed of degeneration in progressive disorders 
(e) the extent of any intellectual impairment 
(f) the social support available, and 
(g) the family circumstances of the people seeking treatment.38 
 
III. WHY PROHIBIT NON-MEDICAL SEX SELECTION? 
 
In just under 15 years the regulation of sex selection for non-medical reasons has shifted from 
guidance that clinics ‘must not’,39 ‘are expected not to’,40 or ‘should not’41 perform it, to a 
criminal prohibition on using PGD for these reasons.  This change merits investigation 
because, in general, the 2008 Act’s amendments to the original 1990 Act were more 
permissive in nature, including removing the requirement to consider the child’s need for a 
father and introducing, in essence, a presumption to treat unless ‘significant harm or neglect’ 
is predicted.42  In contrast, using PGD to identify an embryo’s sex for non-medical reasons 
was subject to more prohibitive treatment.  While the amended 1990 Act removed many 
obstacles to access to other controversial procedures, such as the use of PGD to create 
                                                                                                                                                                                    
condition’ (2007) 15 Medical Law Review 320; S Holm, ‘Ethical Issues in Preimplantation Diagnosis’ in J 
Harris and S Holm (eds.) The Future of Human Reproduction (Oxford University Press: Oxford, 1998). 
38 HFEA, Code, 8th edn, n 18 above, para 10.7. 
39 HFEA, Code, 3rd edn, n 17 above, para 7.20; HFEA, Code, 4th edn, n 18 above, para 7.20; HFEA, Code, 5th 
edn, n 18 above, para 9.9. 
40 HFEA, Code, 6th edn, n 18 above, para 8.9. 
41 HFEA, Code, 7th edn, n 18 above, G.8.7.1; HFEA, Code, 8th edn, n 18 above, 9B and 10D. 
42 1990 Act, s 13(5); HFEA, Code 8th edn, n 18 above, paras 8.3, 8.10, 8.11, 8.15, respectively. 
 ‘saviour siblings’, non-medical sex selection was criminalised.  This appears to have been 
based on notions of harm and the welfare of the child, and public opinion in support of a 
prohibition. We say ‘appears’ because the reasons for putting into legislation the HFEA’s 
policy prohibiting sex selection for non-medical reasons are not clear, even though Lord 
Darzi, the supporter of the HFE Bill in the House of Lords, said that doing so would ‘giv[e] 
Parliament the opportunity to fully debate the provisions’.43  It might thus be thought that 
debates on the relevant clause would have been extensive, yet a search of Hansard reveals 
otherwise and there was, in fact, minimal discussion of sex selection for non-medical reasons 
in both Houses, perhaps because it was believed to be obvious that its prohibition was both 
necessary and appropriate.  Rather, statements merely supporting the provision were 
common.44 
 
A. The harm principle and the welfare of the child 
For societies which value respect for individual autonomy, the harm principle is a central 
principle that guides the making of law.  Under this principle, ‘the only purpose for which 
power can be rightfully exercised over any member of a civilized community, against his 
will, is to prevent harm to others’, and ‘the conduct from which it is desired to deter him, 
must be calculated to produce evil to some one else’ [sic].45  Thus, if we are to respect the 
autonomous choices of individuals and allow them to have as much control over their lives as 
possible, their choices should only be curtailed where this is necessary to prevent serious 
harm to others.  Many of the provisions of the original 1990 Act and some of the amendments 
to that Act introduced by the 2008 Act, were clearly guided by this liberal presumption of 
avoidance of serious harm.  For example, section 13(5) of both Acts emphasise the need to 
                                                          
43 HL Deb 19 November 2007, col 666, Lord Darzi. 
44 See, for eg., HL Debs 21 November 2007, col 844, Lord Ahmed; 3 December 2007, col 1598, Lord Alton; 
HC Debs 12 May 2008, col 1147, David Arness; 19 May 2008, col 101, Mark Simmonds. 
45 JS Mill, On Liberty and Other Essays, (Oxford University Press: Oxford, 2008) 14, emphasis supplied. 
 consider the welfare of children born as a result of any treatment provided under them, and 
the Science and Technology Committee noted that the HFEA had used a ‘welfare argument’ 
to support their recommendation that sex selection for non-medical reasons should not be 
permitted.46  Thus, the HFEA stated that: 
 
the most persuasive arguments for restricting sex selection technologies, besides the 
potential health risks involved, are related to the welfare of the children and families 
concerned … that children selected for their sex alone may in some way be 
psychologically damaged by the knowledge that they had been selected in this way as 
embryos.47 
 
Furthermore, ‘[i]n reaching a decision we have been particularly influenced by the 
considerations ... relating to the possible effects of sex selection for non-medical reasons on 
the welfare of the child born as a result, and by [public opinion]’.48  We discuss the later in 
Section B below. 
 
In earlier editions of the HFEA’s Code of Practice, the legal requirement to consider the 
welfare of children was consistently interpreted to include subjective factors such as the 
potential parents’ ‘commitment to raise children’, their ‘ability to provide a stable and 
supportive environment for a child/children’, and their ‘age, health and ability to provide for 
the needs of a child/children’.49  A high threshold of welfare was thus suggested and anything 
                                                          
46 House of Commons, n 24 above, para 272. 
47 HFEA, Sex Selection: Options for Regulation – A report on the HFEA’s 2002-3 review of sex selection 
including a discussion of legislative and regulatory options (HFEA: London, 2003), para 139, emphasis 
supplied. 
48 HFEA, n 47 above, para 147, emphasis supplied. 
49 HFEA, Code, 6th edn, n 18 above, para 3.12.  Previously, HFEA, Code, 5th edn, n 18 above, para 3.13; HFEA, 
Code, 4th edn, n 18 above, para 3.17; HFEA, Code, 3rd edn, n 17 above, para 3.15; HFEA, Code of Practice 
(HFEA: London, 2nd edn, 1993) para 3.16; HFEA, Code of Practice (HFEA: London, 1st edn, 1991) para 3.14. 
 less than optimal responses, whatever those might be, could result in a clinic being wary of 
providing treatment.  Indeed, such welfare formulations led to some NHS clinics restricting 
access to fertility treatment to relatively young healthy women in established heterosexual 
relationships where there were no obvious risk factors such as genetic diseases or a history of 
abuse or neglect.50  In 2005 the HFEA undertook a consultation with the public, patients, 
doctors and other professionals on welfare of the child considerations,51 which resulted in a 
move away from this reading of the welfare of the child provision as the HFEA concluded 
that: 
 
there should be a presumption towards providing treatment to those who request it, 
but that treatment should be refused in cases where clinics conclude that the child to 
be born, or any existing child of the family, is likely to suffer serious harm.52 
 
In deciding whether to treat, the current Code focuses on ‘factors that are likely to cause a 
risk of significant harm or neglect to any child who may be born or to any existing child of 
the family’.53  These include any ‘aspect’ of their (and/or their partner’s) ‘past or current 
circumstances that may lead to any [existing or to-be born] child … experiencing serious 
physical or psychological harm or neglect’, referring to previous convictions relating to 
children, any child protection measures, or ‘violence or serious discord in the family 
environment’.54  Past or current circumstances which might indicate an ‘inability to care’ for 
an existing child or one to-be-born will also be considered, including addiction problems, 
                                                          
50 N Gamble, ‘Considering the need for a father: The role of clinicians in safeguarding family values in UK 
fertility treatment’ (2009) 19 Suppl. 1 Reproductive BioMedicine Online 15; R Bennett and J Harris, ‘Restoring 
Natural Function: Access to Infertility Treatment Using Donate Gametes’ (1999) 2 Human Fertility 18. 
51 HFEA, Tomorrow’s Children: A consultation on guidance to licensed fertility clinics on taking in account the 
welfare of children to be born of assisted conception treatment (HFEA: London, 2005). 
52 HFEA, Tomorrow’s Children: Report of the Policy Review of Welfare of the Child Assessments in Licensed 
Assisted Conception Clinics (HFEA: London, 2006) 6, emphasis supplied. 
53 HFEA, Code, 8th ed., n 18 above, para 8.10, emphasis supplied. 
54 Ibid, emphasis supplied. 
 medical history, or ‘circumstances that the centre considers likely to cause serious harm to 
any child mentioned above’.55  Thus, apart from the latter factor, the Code now appears to 
focus decisions about whether particular individuals or couples should be provided with 
treatment on evidence that serious harm will befall existing or to-be-born children as a result 
of that treatment being provided. 
 
In line with this general adherence to the harm principle as a guide to regulation in this area, 
in 2003 the HFEA stated that: 
 
[t]he main argument against prohibiting sex selection for non-medical reasons is that 
it concerns that most intimate aspect of family life, the decision to have children.  
This is an area of private life in which people are generally best left to make their own 
choices and in which the State should intervene only to prevent the occurrence of 
serious harms, and only where this intervention is non-intrusive and likely to be 
effective.56 
 
Indeed, the HFEA is generally committed to the democratic or liberal presumption that 
individual choices, in this case reproductive choices, should only be interfered with in order 
to prevent serious harm to others, and many of the provisions of the amended 1990 Act 
reflect this.57  On this basis, it would seem that the only reason for prohibiting non-medical 
sex selection would be because it is thought to cause serious harm. 
 
                                                          
55 Ibid, emphasis supplied. 
56 HFEA, n 47, para 132, emphasis supplied.  For criticism of this report see, for eg., J Harris, ‘Sex selection and 
regulated hatred’ (2005) 31 Journal of Medical Ethics 292; J Harris, ‘No sex selection please, we’re British’ 
(2005) 31 Journal of Medical Ethics 286; T Baldwin, ‘Reproductive liberty and elitist contempt: Reply to John 
Harris’ (2005) 31 Journal of Medical Ethics 288. 
57 Harris, ‘Sex selection’, n 56 above. 
 1. Serious harm to the child-to-be-born 
Assessing the expected levels of harm an action is likely to cause existing children is often 
difficult but it is usually easier to quantify than assessments of harm to those who have yet-
to-be-born.  There are two main ways of thinking about future lives and serious harm.  First, 
there are lives that are sometimes called ‘unworthwhile’.58   These are lives that we think are 
likely to be dominated by suffering and where negative experiences are likely to outweigh 
positive ones.  Given this, life itself could be seen as a serious harm to this child as it brings 
overwhelming pain and suffering.  Thus, we might consider bringing a child to birth in this 
condition a harm in itself.  If it is this kind of serious harm that we are trying to avoid, we 
need to ask ‘would existence itself be a serious harm or an overall negative experience for the 
resulting child?’  If we consider existence generally to be a good thing and accept that most 
people will have a life they will value and want to continue, then such instances of not 
worthwhile lives will be rare and restricted to lives of extreme and unrelenting suffering.59  A 
second way of thinking about serious harm involves asking whether the future child is likely 
to suffer any foreseeable serious harm.  The question is, ‘is this child likely to suffer serious 
physical or psychological harm even if she is still likely to have a life that she will value?’  
We are not asking whether life itself would constitute a serious harm for the child born but 
whether its life would be compromised by what could be considered to be serious harm.   
 
Historically, both ways of looking at harm and the welfare of the child were in evidence in 
the HFEA’s Code of Practice and the legislation it was founded on.  Thus, cases involving the 
first type of harm, where a life would be completely ‘blighted’ by suffering, would be clear-
cut cases of refusal of treatment and fairly rare.  The more common discussions on the 
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 welfare of the child would be whether this child is likely to suffer serious physical or 
psychological harm, although such harm would be unlikely to blight that life completely.  As 
we have noted, considerations such as  ‘commitment to raise children’, their ‘ability to 
provide a stable and supportive environment for a child/children’, and their ‘age, health and 
ability to provide for the needs of a child/children’,60 were considered important when 
assessing the likely welfare of the resultant child, even though failures to reach optimal levels 
of commitment, supportive environments or the health of the would-be parents would be 
unlikely to create a child who has a life we might consider not worth living or a harm in 
itself. 
 
The amended Act and updated Code raise the threshold to an assumption of treatment unless 
there is evidence that serious harm will befall the resultant child.  However, it is still not clear 
that this consideration is restricted to only those rare cases where lives are likely to be 
completely blighted by suffering.  Deciding which of these senses of serious harm should be 
adopted when considering the welfare of children born following assisted reproduction is 
important, but it is not our focus here.61  Instead, concern for the welfare of the future child 
on the basis of (serious) harm cannot be a reason to prohibit sex selection for non-medical 
reasons because there is no evidence that using PGD for these reasons will lead to either kind 
of serious harm to the welfare of the future child.  Indeed, in its report on sex selection, the 
HFEA offered no evidence to support its conclusion that selection for non-medical reasons 
should be prohibited because of hypothetical risks to the welfare of a sex-selected child and 
its family, other than the concerns expressed in the public consultation, as we discuss in 
Section B below.62  Referring to this report and the HFEA’s position, the Science and 
Technology Committee stated that ‘the most persuasive argument was not that there was 
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 evidence of harm but that there was evidence of concern about harm.  This is not a 
satisfactory use of evidence to support policy advice’.63  The Committee concluded that ‘[t]he 
onus should be on those who oppose sex selection for social reasons using PGD to show 
harm from its use’,64 and that ‘[t]he UK should carefully consider the current evidence there 
[is] available now about [gender] imbalances and harms before allowing blanket changes [to] 
our laws and regulations on sex selection’.65  Furthermore, it noted that ‘[t]he HFEA has 
drawn on theoretical psychosocial harms in formulating policy on sex selection, invoking the 
precautionary principle.  It concerns us that the potential for harm is often quoted without 
recourse to a growing body of evidence of its absence’.66 
 
Without such evidence it is only possible to posit the harm that might be caused by using 
PGD to select an embryo on the basis of its sex for non-medical reasons, but not for medical 
reasons?  It is possible that allowing parents to select to implant an embryo of a particular sex 
may cause the child some psychological difficulties or pressures as a result, but similar 
pressures that may be exerted on other children not selected in this way.  It is hard to imagine 
these difficulties being so serious that they would cause the selected children harm, let alone 
harm so serious that it would obliterate the positive attributes that life has brought them.  
Parents who select the sex of their child in this way may be overbearing or have a particular 
idea of the sort of child they wish to have.  Perhaps they want a child who will be a ballerina 
or a rugby player and hope that sex selection will help them reach this goal.  However, many 
children have overbearing parents, parents who have strong ideas about how their children’s 
lives should go and this may make us feel sorry for these children and try and remonstrate 
with their parents.  But it is unlikely to make us feel that allowing these parents to create 
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 these children in this environment, in the only environment they could have been created, was 
a wicked and deplorable act.  This is particularly as the children are as likely to value their 
lives as any other children.  Indeed, children born as a result of using PGD to select sex for 
non-medical reasons may have what might be considered a sub-optimal life, but their life is 
as likely as any other to be one that they value overall.  So, whatever view we take on what is 
meant by serious harm, it is difficult to see how a concern to protect future children from that 
harm can justify the prohibition on sex selection for non-medical reasons. 
 
While children born as a result of using PGD to select sex for non-medical reasons may have 
what might considered to be a sub-optimal life, their life is as likely as any other to be one 
that they value overall.  Indeed, it is difficult to understand how sex selection for non-medical 
reasons is likely to cause serious harm to the individual born as a result of this selection 
process.  In fact, it is difficult to distinguish using PGD for these reasons from using PGD 
generally or for medical reasons with regard to avoiding serious harm and protecting the 
welfare of the resulting child, and also regarding the benefits they may produce.  With regard 
to medical reasons, only a minority of cases will involve the avoidance of catastrophic 
disorder, a condition that is likely to completely blight that life and make it unworthwhile.  
Most cases of medical sex selection using PGD will be motivated by a desire to avoid serious 
disorders which are unlikely to render lives not worth living; for example, haemophilia, 
muscular dystrophy or Turner Syndrome.  Thus, where medical sex selection is sanctioned, 
the choice may be between two worthwhile lives.  If PGD is used to avoid a sex linked 
disorder and a child is born with a disorder that is unlikely to render her life unworthwhile, no 
child’s welfare has been damaged.  The affected child is born in the only state she can be 
born in and is likely to value her life as much as anyone else, albeit with physical and/or other 
complications that may require treatment.  Medical sex selection does not ‘save’ anyone from 
 living with a serious disorder.  A different unaffected child is born as a result of PGD, rather 
than one individual being saved from this ‘plight’.  In most cases, using PGD for sex 
selection is not used to prevent serious harm to an identifiable individual but to allow 
prospective parents a chance to be a parent of the sort of child they wish to parent.   
 
Thus, using PGD to identify an embryo’s sex for medical reasons is not usually undertaken 
with the welfare of the child in mind.  In most cases, we are not likely to affect the welfare of 
any individual child and we are not choosing between worthwhile lives.  Instead, using PGD 
for medical reasons enables parents to have the child they want.  The welfare of particular 
children is not affected by the choice between embryos, but the interests of the prospective 
parents may be better served if they are able to choose to be the parent of a child with less 
obstacles to overcome.  The same is true with the benefits of using PGD to select sex for non-
medical reasons.  In both cases parents wish to use PGD so that they can be a parent of a 
child with particular characteristics, and in both cases their choices do not, usually, have an 
impact on the welfare of the child-to-be. 
 
In fact, taking this more widely, sex selection using PGD for non-medical reasons is in line 
with the general ethos of IVF and other assisted reproductive processes (such as surrogacy) 
more generally, which is to enable prospective parents to have a child with a particular 
characteristic – a genetic link to them.  There are other options that would allow them to be a 
parent (such as adoption or sperm donation), but, in many cases, prospective parents prefer to 
have a child who is genetically related to one or both of them.  It would, in fact, be more 
straightforward, cheaper and safer, for instance, to offer insemination with donated sperm 
instead of IVF using Intracytoplasmic Sperm Injection (ICSI), but we take the desire to have 
a genetically related child so seriously that we allow this use of resources and risk of some 
 harm (all IVF involves some risk to the female partner as a result of hyperstimulation of the 
ovaries),67 in order to allow individuals a chance of parenting a child with the characteristics 
they want.  So, some IVF is about having a child of a particular kind, not for medical reasons 
but because the parents want a child who has particular characteristics (genetically linked to 
them).  Although some may think that this genetic link is not important, and we have 
evidence from adoption that it is possible to bond and have fulfilling relationships without 
this genetic link, when it comes to being a parent and having the desired parent-child 
relationship, this evidence does not change the fact that for many this link is important and 
will remain a relevant factor when they consider their reproductive choices.  This is 
comparable with the case of sex selection for non-medical reasons.  We can explain to people 
that we think that the sex of their child should not be important and that they should be 
prepared to parent a child of either gender, but this is unlikely to change their desire for a 
child of a particular sex. 
 
In general, assisted reproduction allows individuals to parent the children they wish to 
including choosing the characteristics of those children.  As the Department of Health has 
acknowledged, other forms of gamete and embryo selection are well-established and accepted 
within, for example, donor insemination, where the physical characteristics of the donor are 
selected so that any resulting child may resemble those receiving treatment.68  Within this 
general context of enabling choice regarding the children we can be parents to, sex selection 
for non-medical reasons does not seem so different in character or cost benefit analysis to that 
of other more generally acceptable assisted reproduction procedures.  Given this, if the harm 
principle is to be used to justify the prohibition on non-medical sex selection then some other 
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 kind of harm must be evoked.  Might sex selection for non-medical reasons cause serious 
harm to society? 
 
2. Serious harm to society 
In one of the HFE Bill debates in the House of Lords, Baroness Williams said that: 
 
There is so much at stake - so much money - in people, for example, being able to 
determine such things as the sex of their own child.  Many noble Lords will know that 
the built-in hereditary preference for boys over girls has produced a surplus of what is 
estimated to be over 30 million young males in China, as against the women that they 
might one day marry.  The social consequences of that are absolutely terrifying.  They 
are the consequences of producing a warrior people – a warrior race if you like.  We 
have to think about the social consequences.69 
 
She suggested that the refusal to allow sex selection was one of three ‘fragile dikes’ (the 
others being embryo destruction after 14 days and the prohibition on cloning), and that: 
 
If we are to remain in a civilised world – one that fully accepts the huge benefits of 
science but recognises that there are limits to what people should do in using other 
people for certain purposes – then these dikes must hold.  We need all the help we can 
get in doing that.70 
 
Similar comments were made in the 1984 Warnock Report where it was noted that sex 
selection for non-medical reasons ‘would obviously affect the individual family and the 
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 children involved, and would also have implications for society as a whole’.71  While it was 
‘impossible to predict’ the effect on the male-to-female ratio in society, ‘important social 
implications’ could follow if males were chosen to be the first born and ‘there is considerable 
evidence that the firstborn sibling may enjoy certain advantages over younger siblings’.72  
Sex selection might have ‘particular implications for the role of women in society’.73  Thus: 
 
 [t]hese important considerations make the Inquiry dubious about the use of sex 
selection techniques on a wide scale, but because of the difficulty of predicting the 
outcome of any such trend we have not found it possible to make any positive 
recommendations on this issue.  Nevertheless, we consider that the whole question of 
the acceptability of sex selection should be kept under review.74 
 
Other ‘societal’ harms might include the start of a slippery slope if sex selection for non-
medical reasons was permitted,75 one sex being viewed as a ‘harmful trait’,76 gender-role 
expectations being reinforced,77 a consumerist attitude to children developing, or an 
imbalance in a society’s sex ratio thereby being created.78 
 
For these concerns to be, legally and/or morally, relied upon, supporting evidence is surely 
necessary.  Indeed, the Science and Technology Committee declared that ‘[r]eproductive and 
research freedoms must be balanced against the interests of society but alleged harms to 
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 society, too, should be based on evidence’.79  However, as we have noted above and discuss 
further in the following section, the HFEA offered limited evidence for its stance against non-
medical sex selection in its 2003 report.80  The Committee suggested that the precautionary 
principle should apply to human reproductive technologies, meaning that ‘alleged harm to 
society or to patients needs to be demonstrated before progress is unduly impeded’.81  If it 
cannot be shown that non-medical sex selection is likely to cause serious harm to the welfare 
of individual children or wider damage to society, then what justified the prohibition on the 
use of PGD for these reasons?  We suggest that fear of a risk of serious harm, as seemingly 
demonstrated by public opinion, played a significant role.  
 
B. Public Opinion 
 
As we noted in Part II, during 2005 the Government undertook a public consultation on the 
1990 Act and a summary of that consultation was published in March 2006.82  The 
consultation document noted that, as we discuss further below, a MORI survey in 2003 had 
‘found strong public opposition to sex selection for non-medical reasons’ and that the Science 
and Technology Committee had been unable to justify prohibiting sex selection for family 
balancing reasons.83  The Government thus sought views on sex selection for non-medical 
reasons and while there were 535 respondents to the consultation in total, no figures are 
provided regarding responses to each question.84  The report on that consultation stated that 
arguments for and against sex selection were received but that within societies and 
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 organisations there was no consensus on sex selection.85  Nevertheless, in the White Paper of 
2006 it was said that ‘it was clear that responses generally favoured measures such as a ban 
on sex selection of offspring for non-medical reasons’, and that ‘[s]ociety’s collective and 
considered opinion is the ultimate arbiter of the controls to be applied to the development and 
use of human reproductive technologies’.86  The range of opinions in the consultation on 
screening and selecting embryos was noted and it was concluded that there was a ‘general 
desire’ for the law to be clearer.87  As part of this, Parliament was to define the limits or 
criteria regarding testing embryos,88 and: 
 
the Government is persuaded that sex selection for non-medical reasons within 
treatment services should be prohibited, including for “family balancing”.  This 
reflects, in part, the strength of public opinion on this matter that this should not be a 
matter for choice open to potential parents’.89 
 
Both the draft bill of May 2007 and the HFE Bill included statutory prohibitions on selecting 
an embryo on the basis of sex for non-medical reasons,90 and the Joint Committee on the 
May 2007 bill stated that ‘[s]ome attempts … have been made to measure public opinion [on 
sex selection of embryos for non-medical reasons]’ and that the Chief Executive of the HFEA 
had told them that the HFEA had ‘found that largely very overwhelmingly the public in this 
country were opposed to sex selection for non-medical reasons’ and that ‘it’s policy on sex 
selection has public support on the basis of this public consultation’.91  The Joint Committee 
was, however, cautioned by the Royal Society about the use of apparent ‘public opinion’ in 
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 policy making and the need to ensure that public engagement was ‘methodologically rigorous 
based on principles of effective public engagement and any support material must be 
scientifically sound’, and we consider this further in Part IV.92  Nevertheless, the idea that 
‘the public’ supported a ban on sex selection for non-medical reasons was explicitly 
reiterated in the House of Lords debates on the HFE Bill where Baroness Deech stated that 
‘[t]he public came out very clearly against sex selection for social reasons and that has 
remained the rule of the [HFEA] and it is in the Bill’.93  Furthermore, in the House of 
Commons Alan Johnson, the sponsor of the Bill, declared that ‘[f]ollowing the results of the 
public consultation, the Bill also outlaws sex selection for non-medical reasons’.94 
 
Given the limited number of respondents to the 2005 consultation on human fertilisation and 
embryology, it is important to examine claims that ‘the public’ are not in favour of sex 
selection for non-medical reasons to determine their validity and reliability.  Tracing the 
history of this claim, the HFEA launched its first public consultation on sex selection in 
1993.95  The consultation document explained the legality of medical sex selection, the 
‘ethical issues surrounding the reasons for sex selection’, and noted that ‘some reasons for 
sex selection may be more ethically acceptable than others’.96  General considerations 
relating to sex selection were set out,97 and three arguments were listed in favour of non-
medical sex selection and four against it.98  The only details of the public consultation were 
published in a letter dated 15 July 1993 from Sir Colin Campbell, the then chair of the HFEA, 
to the Parliamentary Under-Secretary of State for Health.  It stated that the Authority was 
‘persuaded by the arguments set out in the [public consultation] document against the use of 
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 sex selection for social reasons’,99 and all licensed clinics would be written to and ‘advised’ 
not to undertake non-medical sex selection, with this advice incorporated into subsequent 
Codes of Practice.100  Public response to the consultation was said to be ‘limited’ (the number 
of respondents was not provided), but 67% ‘of those respondents who discussed the issues in 
general terms’ were opposed to sex selection for non-medical reasons.101 
 
The HFEA subsequently disclosed that 2,000 copies of the consultation document were 
issued and 165 responses received.102  The most common public concern over non-medical 
sex selection was reinforcing gender stereotypes to women’s disadvantage, with other 
concerns including ‘a “slippery slope” towards selecting the “perfect child”’, children being 
seen as ‘consumer goods’, and the effect on the family of using the techniques, regardless of 
success.103  The HFEA concluded that ‘while the arguments on this issue are complex, the 
view of the Authority on sex selection for social reasons is strongly supported by the public 
who responded to our consultation exercise’.104  Nevertheless, the HFEA would ‘be keeping 
the matter under review in the light of any new information or changes in public opinion’.105  
Following this consultation, the HFEA’s Code of Practice was amended and, as we noted in 
Part I, the Code has consistently stated that embryos should not be selected on the basis of 
sex ‘for social reasons’.106 
 
Using PGD to identify embryos with genetic disorders, for medical reasons only, was 
considered in a joint consultation by the HFEA and the Advisory Committee on Genetic 
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 Testing in 1999.107  There were 171 responses to this consultation (47 from organisations and 
124 individuals) and 88 of 119 respondents (74%) agreed that PGD should be used to select 
an embryo on the basis of its sex for ‘a limited number of specific serious inherited 
conditions’.108  It was thus recommended that ‘PGD should only be available where there is a 
significant risk of a serious genetic condition being present in the embryo’.109  Similarly, the 
Nuffield Council on Bioethics discussed PGD in its 2002 report on genetics and human 
behaviour,110 and recommended that its use continued to be limited to ‘serious diseases and 
disorders’ rather than increased to include behavioural or personality traits.111  While not 
specifically considering using sex selection for non-medical reasons, the Council said that 
‘there seems to be a consensus in clinical genetics and in public opinion against [the] use of 
PGD ... in order to select babies on the basis of non-clinical characteristics’.112  The basis for 
this statement is unclear, but it may be that more recent claims about public opinion can be 
traced back to the results of the Government’s request, in 2002, for the HFEA to consider sex 
selection via a number of strands - a scientific report on sex selection techniques,113 market 
research involving a cross section of the public to ‘map out their perceptions of the issues 
[raised by sex selection] and identify the ways in which they resolve potentially conflicting 
views’,114 an opinion survey,115 a literature review on the ethical and special issues raised by 
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 sex selection,116 and a public consultation document, with sperm sorting its primary focus.117  
This document set out arguments for and against sex selection, and included comments from 
participants in the market research. 
 
These results of the consultations were published in 2003.118  For the market research, group 
discussions were held with 12 groups of adults over 18 between 18 June and 16 July 2002 in 
Birmingham, Belfast, Cardiff, Edinburgh and London.119  Participants were not told in 
advance of the topic for discussion, which was introduced by a moderator who guided the 
group through the issues raised by the initial question ‘what comes to mind when I say “sex 
selection” to you?’120  Reported conclusions included that ‘[a]lmost no-one was aware of sex 
selection, for any reason, thus when it was mentioned, respondents immediately imagined sex 
selection as being for social reasons’, but that ‘[o]nce prompted, respondents tended to argue 
for the current practice of allowing sex selection because of a genetic disease which affects 
only one sex’.121  Furthermore, ‘although they had no idea of how sex selection might be 
achieved, they all assumed it would involve major intervention’ and ‘[t]heir immediate, or 
“gut” reactions tended to be fairly strong and usually negative’.122  Participants also ‘felt that 
there was a necessary difference between parents trying to avoid suffering which was likely 
to occur in future children, and parents wanting a specific type of child’,123 and ‘[m]ost 
within the sample felt that, whatever the method used, non-medical reasons, and 
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 insufficiently serious medical reasons were not grounds to justify sex selection’, with non-
medical reasons causing ‘major discomfort within the groups’.124  Participants requested that 
‘a reasonable debate … take place; that the debate has a moral and family dimension, and not 
simply take place on the question of whether people should have a choice or not’,125 and it 
was reported that a ‘minority’ of the participants (number not stated) thought that as the 
technology existed and sex selection did no harm, people should have access to it.126 
 
Questions on sex selection were also placed on the regular MORI survey of the public (the 
MORI Omnibus), and 2,165 people over 16 interviewed face-to-face in their homes 
throughout Britain between 9 and 14 January 2003.127  14% of the respondents (306/2165) 
agreed that ‘any prospective parent should have the right to choose the sex of their child’, 
68% (1466/2165) that ‘sex selection should be regulated’,128 and 65% (731/1123) that sex 
selection through testing embryos created outside the body should only be permitted for 
medical reasons.129  18% (200/1123) agreed that sex selection should be permitted for 
‘“family balancing” (having a child of a different sex when there are only children of one sex 
in the family)’, and 8% (85/1123) for ‘any social or cultural reason, or reasons of individual 
choice’.130  Despite these apparently clear opinions in favour of regulation and against non-
medical sex selection, only 21% (465/2165) correctly identified that sex selection involved 
choosing a baby’s sex and there was general ignorance about the possibility of sex 
selection,131 although 80% of respondents (1722/2165) subsequently identified reasons why 
couples might want to choose the sex of their baby.132  The disparity between the 
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 respondents’ limited knowledge of sex selection and their predominantly negative responses 
to it are interesting, and the value of the research would undoubtedly have been strengthened 
if information on the technology had been provided and the questions asked again to 
determine whether that altered or affected their opinions.  Without such, the allegation that 
views were sought from an uninformed selection of the public is hard to refute.  Nevertheless, 
Suzi Leather, the then chair of the HFEA, declared that ‘[o]ur survey of a representative 
sample of the population clearly indicates that there is a general moral consensus in the 
United Kingdom against parents selecting the sex of their children for primarily personal 
reasons like “family balancing”’.133 
 
Finally, the 2002 public consultation document was sent to 248 organisations and the public 
could write and request a copy of it or download it from the HFEA’s website.  641 valid 
responses were received (66 from organisations and 575 from individuals),134 but not all 
respondents answered the eight questions set out in the document.  Of those who did, 83% 
(489/589) disagreed that PGD should be permitted for selecting sex for non-medical 
reasons,135 83% (489/589) also disagreed that sex selection by sperm sorting or PGD should 
be permitted ‘for non-medical reasons when a family has at least two children of one sex and 
none of the other sex’ (family balancing),136 and 85% (501/589) disagreed that sex selection 
by sperm sorting or PGD should be permitted for ‘non-medical reasons other than family 
balancing’.137  Following these consultations and surveys, the HFEA concluded that ‘[t]he 
strength of opposition to sex selection for any but serious medical reasons revealed by this 
consultation is clear’,138 there was no need to review the permissibility of sex selection only 
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 for medical reasons, and this was ‘supported by a clear majority of those in the representative 
national sample polled by MORI’.139  Nevertheless, with regards to the public’s response to 
the 2002 consultation, the HFEA admitted that: 
 
 [a]lthough the consultation was not a scientifically robust way of sampling 
representative public opinion on this subject, it is valuable to note the views of those 
who were sufficiently interested in the issues raised to respond.  Many wrote at 
considerable length to explain why they were answering as they did, and their 




 [i]n reaching a decision we have been particularly influenced by the considerations ... 
relating to … the welfare of the child …, and by the quantitative strength of views 
from the representative sample polled by MORI and the force of opinions expressed 
by respondents to our consultation.  These show that there is very widespread hostility 
to the use of sex selection for non-medical reasons.141 
 
It may have been these consultations and surveys that the Government was referring to in its 
response to the Science and Technology Committee’s 2005 report, when it said that it was 
‘aware of public concerns about the possible use of sex selection techniques for social 
reasons’ and that it, thus, had ‘no plans … to allow sex selection other than for compelling 
medical reasons’.142  The Government also said that it would ‘seek wider public views on 
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 whether sex selection for family balancing purposes should be permitted, as recommended by 
the Committee’,143  and we discussed the most recent consultation at the start of this section.   
 
It is clear that despite consistent and repeated claims of overwhelming public opinion against 
using PGD for non-medical reasons, the validity of these claims are tenuous, to say the least.  
That these have been used to support a criminal prohibition on such use raises, we suggest, a 
number of issues which require consideration before ‘public opinion’ is used again as the 
basis for regulation. 
 
IV. PROBLEMS WITH BASING REGULATION ON PUBLIC OPINION 
 
In 2005 the Science and Technology Committee noted some of the concerns about how 
public opinions were used (and were seen to be used) as the basis for policy.144  Some of the 
practical problems of conducting public consultations should be clear from the above.  These 
include recruiting an appropriate number of participants, and ensuring that they have some 
understanding of the issues and their complexity prior to responding to questionnaires or 
being involved in discussions or interviews.  Beyond this, we suggest that there are other 
problems with regulating on the basis of public opinion.  As it appears that the majority of the 
respondents to the public consultations were against allowing PGD to be used to select an 
embryo on the basis of its sex for non-medical reasons, it might seem that allowing public 
opinion to influence regulation was fairly straightforward.  But what if a consensus was not 
found?  And if regulation is to be based on public opinion regarding non-medical sex 
selection, then why is such opinion not sought or the basis of regulation on other 
controversial and contested issues, such as embryo experimentation or funding fertility 
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 services at all?  This might be because even if we provided information about these issues in 
as balanced a way as possible, consensus is unlikely because of the very nature of the issues 
themselves.  Indeed, a common characteristic of these issues is that they polarise debates.  
But if public opinion is to be the foundation of regulation and public opinion does not provide 
us with a clear direction, then what are we to do?  A compromise may be possible based on 
the results of public consultation, but it is difficult to understand what a true compromise, 
where both sides gain and/or loose in roughly equal amounts, on ethical issues such as these 
would look like.  Indeed, it is difficult to see how a true compromise position can be achieved 
on ethical issues where views are polarised.  Given this, how do, and should, we value the 
views of the people when disagreement on these issues is so divided? 
 
Regardless of these concerns, the HFEA’s policy on not using PGD to select sex for non-
medical reasons, and the subsequent incorporation of this into legislation, appears to have 
been, at the very least, influenced by (supposed) ‘public’ opinion on this issue.  Indeed, the 
HFEA stated that: 
 
By itself this finding [of widespread hostility to permitting sex selection for non-
medical reasons] is not decisive; the fact that a proposed policy is widely held to be 
unacceptable does not show that it is wrong.  But there would need to be substantial 
demonstrable benefits of such a policy if the state were to challenge the public 
consensus on this issue.  In our view the likely benefit of permitting sex selection for 
non-medical reasons in the UK are at best debatable and certainly not great enough to 
sustain a policy to which the great majority of the public are strongly opposed.145 
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 The argument appears to be that while there may not be evidence that using PGD to select an 
embryo of a particular sex for non-medical reasons harms the child who will be born or their 
siblings (and so is morally wrong), the benefits of permitting such use is similarly limited.  
This quote suggests that the HFEA weighed the harms that may be accrued by offending the 
public, whatever they might be, against the benefits that may follow from allowing parents to 
select embryos of a particular sex for non-medical reasons, and determined that the former 
outweighed the latter.  However, as we have discussed in Part IIIA, when the benefits of 
using PGD for non-medical sex selection are examined, we see that they are, in fact, similar 
to those of using it for medical reasons and also for other assisted reproductive procedures, 
including IVF.  This is because they all allow would-be parents the chance of having a child 
with characteristics they desire, whether that be a child they are genetically connected to, or 
one without a particular condition, or a child of a particular sex. 
 
In the Science and Technology Committee’s report the fact that the validity of the data 
gathered by the HFEA in support of its conclusions on sex selection had been questioned was 
noted, but it was said that: 
 
even if the HFEA exaggerates the public’s hostility to sex selection for social reasons, 
we have little reason to doubt that a majority of the British public oppose it.  Professor 
Tom Shakespeare from Newcastle University has provided confirmation of this from 
his own research.  Nevertheless, we do not ‘see this as adequate grounds for 
prohibition’.146 
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 This quote raises two points which deserve further consideration and are relevant to the use 
of public opinion generally and specifically in relation to sex selection.  The first relates to 
the matter evidence.  Tom Shakespeare told the Committee that ‘[i]n our social research into 
“ordinary ethics”, all lay respondents were opposed to social sex selection, and this evidence 
is born out by other surveys, including the HFEA research’.147  He did not, however, provide 
any further information regarding this research nor the other evidence he referred to.  The 
second point relates to the idea that public opinion is not an ‘adequate ground’ for prohibiting 
parents from selecting embryos of a particular sex for non-medical reasons.  Along with our 
general comments at the start of this section on using public opinion as the foundation for 
regulation, John Harris has argued that we have: 
 
some reason to be cautious about claims to the effect that forms of public consultation 
have revealed the moral attitudes or values of the public, and that these must both be 
respected and inform public decision-making.  If what is informing public decision-
making is a collection of recorded prejudices or evidence of slavish and uncritical 
adherence to a sectarian normative system, then perhaps the respectability, if not the 
authenticity, of the voice of the people requires challenge rather than faithful 
reporting and incorporation into the decision-making process.148 
 
If we rely on public opinion in policy making then we must accept that many of those who 
respond to public consultations are likely to provide an intuitive ‘gut’ reaction to the issue.  
Such reactions may be based on false information, prejudice and fear.  They may also be 
inconsistent with some of their other views and, therefore, difficult to defend or justify.  The 
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 Joint Committee on the draft Bill of May 2007 recognised some of the problems of relying on 
public consultations, and said that ‘[r]esponses to public consultations often come from those 
with strong views which may not be representative of those held by the general public.  
Those who reply to public consultations are by their nature self-selecting’.149   
 
There are limits to what public consultations can do and the use to which the results of them, 
and so ‘public opinion’, should be put.  Indeed, the Joint Committee was ‘concerned by the 
unsubstantiated claims made about public opinion and public support and by the lack of 
evidence provided’ and we agree that ‘[w]here organisations claim to speak on behalf of the 
public, they should have a proper research basis to do so that is capable of scrutiny’.150  
Public consultation may enable us to find out what some people’s gut reaction to particular 
ethical issues are, but it will not necessarily help us to determine the moral acceptability of a 
practice nor how we should regulate (or not) it. 
 
V. CONCLUDING REMARKS 
 
The preferred way to determine how we should regulate practices such as non-medical sex 
selection is to examine the evidence and provide a reasoned, consistent and defendable 
position, and it was on this basis that the Science and Technology Committee, in 2005, 
concluded that it could ‘find no adequate justification for prohibiting the use of sex selection 
for family balancing’.151  However, even though there was no evidence that using PGD to 
select an embryo on the basis of its sex for non-medical reasons alone will harm anyone, the 
amendments to the 1990 Act introduced by the 2008 Act make it a criminal offence to use 
PGD for such reasons.  This provision placed on a statutory footing HFEA policy since 1995, 
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 policy which has consistently been said to be based on fear harm, the idea that the benefits of 
such selection are significant enough to outweigh these unsubstantiated harms, and that this 
position is supported by public opinion.  Although the Science and Technology Committee 
shone a spotlight on the fallacies of this position, this was ignored by a Government 
seemingly convinced of the merits and popularity of stance. 
 
Using public opinion to guide regulation is difficult and it is hard to formulate questions that 
do not lead opinion in one direction or another.  Using public opinion as the basis for 
regulation may result in contradictory regulation or regulation that is inconsistent and 
unstable and it may need frequent updating.  Public opinion changes over time as social 
norms evolve and as the public becomes more familiar with, and, possibly, more accepting of 
certain practices.  Relying on public opinion for guidance on regulation is, at the very least, 
practically problematic.  As a result, there are few calls for regulation to be informed in this 
way.  The classic example here is that although the majority of respondents to polls are in 
favour of capital punishment for some crimes, there has never been a serious attempt to allow 
public opinion to influence the legal stance on this form of punishment in England and 
Wales.152  While public opinion should not be dismissed, it is difficult to see why public 
opinion should be allowed such an influence in some situations, such as non-medical sex 
selection, but not in others.  This is particularly troubling where this results in policy which is 
inconsistent with the approach to other comparable practices. 
 
A reasonable and defendable position on sex selection is required and a consistent position is 
needed which is based on clear and explicit foundations.  This will help guide us when we are 
faced with new challenges in this area.  The position should be as consistent as possible with 
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 other regulation and policies in the area, so that that regulation is ‘more stable’ and less likely 
to be amended or repealed.  This was one of the aims of the amendments introduced by the 
2008 Act153 and, in general, this is what was achieved.  Some of those amendments moved 
the original 1990 Act away from judgements about individuals’ abilities to be good parents 
towards an assumption to treat unless there was evidence of serious harm to the resultant 
child.  This is, essentially, an adoption of a classic harm principle approach to legislation that 
recognises the importance of reproductive autonomy and reproductive opportunities.  In 
doing so, it moves away from the idea that children who are born into the only conditions 
they can be born into, and who are likely to value their lives as much as any of us, are harmed 
by this ‘suboptimal’ but still worthwhile existence. 
 
But this general approach stops when we look at using PGD to identify the sex of embryos 
for non-medical reasons.  Although it is admitted that there is no evidence that children born 
for these reasons will suffer serious harm, this practice is not only prohibited but is 
criminalised on the basis that there is not enough evidence of the benefits in order to 
outweigh the supposed public distaste for sex selection for these reasons.  We suggest that it 
is a mistake to distinguish between selecting an embryo on the basis of its sex for non-
medical reasons from other assisted reproductive techniques because they are comparable.  
Medical sex selection, and IVF more generally, are often used to create a child with particular 
characteristics, such as one who is free of a sex linked disorder or who is genetically related 
to their parents.  The motivation, in most cases, is to be a parent to a child with these 
particular characteristics, rather than pure concern for the welfare of the resultant child.  
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 Indeed, in most cases, even in medical sex selection cases, the disorder that we are trying to 
avoid is not one that would ‘blight’ that child’s life and make that life not worthwhile.  We 
would expect a child who is born with most of these disorders to have a challenged but still 
worthwhile life, a life that they would be likely to value as much as the next child.  Given 
this, it is not as easy to distinguish between using PGD to select embryos of a specific sex for 
medical and non-medical reasons as might first be presumed. 
 
The 2008 Acts’ amendments to the 1990 Act, in general, introduced a clear moral stance on 
the regulation of assisted reproduction, with an explicit foundation in the harm principle and 
a commitment to reproductive autonomy.  Yet, non-medical sex selection was singled out for 
different treatment.   As a result, we have a general approach to regulation which is based on 
reason, evidence and critical thinking about the issues in hand, with one issue treated 
differently without good reason.  Here, the cry of ‘it’s what the public wants’ has been used 
to endorse the prohibition on using PGD to select an embryo on the basis of its sex for non-
medical reasons only.   The singling out of non-medical sex selection is both curious and 
indefensible.  We hope that the use public opinion as the basis for regulation is carefully 
considered and that it remains the exception rather than the rule. 
